Guangzhou PackGene Biotechnology Co.
Latest round
- Series C
Last raised
- Dec 2023
Total raised
- $14M
Investors
- 11
About Guangzhou PackGene Biotechnology Co.
,Ltd operates as an adeno-associated virus (AAV) R&D manufacturer, specializing in AAV viral vector packaging CRO and CDMO services. It has branch offices in Shanghai, Boston and Switzerland. Some enterprises and universities, such as Sun Yet-sun University, Einstein, and South Western Medical Center, have cooperated with the company. In July 2022, Genemagic Biosciences became the strategic partner of the company. The company provides CRO and CDMO services focused on recombinant adeno-associated virus (AAV) vector packaging. CRO services include in-stock plasmid and AAV virus, AAV custom packaging, plasmid DNA cloning, plasmid extraction, AAV and plasmid analysis and testing services, and new crown research tools. CDMO services are divided into three series, which are plasmid CDMO services, AAV CDMO services, and CMC filing services. PackGene Biotech also developed a testing services platform and technology platform such as p-Alpha™ 293 cell AAV high yield technology platform, p-Omega™ plasmid DNA high yield platform, and p-Icosa™ AAV serotype screening platform.
Who invested in Guangzhou PackGene Biotechnology Co.
11 investors across 5 rounds
See all investors in Guangzhou PackGene Biotechnology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Guangzhou PackGene Biotechnology Co.
Who invested in Guangzhou PackGene Biotechnology Co.?
Guangzhou PackGene Biotechnology Co. has 11 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Guangzhou PackGene Biotechnology Co. raised?
Guangzhou PackGene Biotechnology Co. has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Guangzhou PackGene Biotechnology Co. last raise money?
Guangzhou PackGene Biotechnology Co.'s most recent round on record is a Series C, in Dec 2023.
What does Guangzhou PackGene Biotechnology Co. do?
,Ltd operates as an adeno-associated virus (AAV) R&D manufacturer, specializing in AAV viral vector packaging CRO and CDMO services.
Where is Guangzhou PackGene Biotechnology Co. headquartered?
Guangzhou PackGene Biotechnology Co. is headquartered in Guangzhou, China.
Which VCs invest in companies like Guangzhou PackGene Biotechnology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Guangzhou PackGene Biotechnology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Guangzhou PackGene Biotechnology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.